» Articles » PMID: 28755323

Detection of the Alternative Lengthening of Telomeres Pathway in Malignant Gliomas for Improved Molecular Diagnosis

Abstract

Human malignant gliomas exhibit acquisition of either one of two telomere maintenance mechanisms, resulting from either reactivation of telomerase expression or activation of an alternative lengthening of telomeres (ALT) mechanism. In the present study, we analyzed 63 human malignant gliomas for the presence of ALT-specific extrachromosomal circles of telomeric DNA (C-circles) and measured telomerase expression, telomeric DNA content (Telo/Alu method), and telomeric repeat-containing RNAs (TERRA) levels. We also assessed histomolecular markers routinely used in clinical practice. The presence of C-circles significantly correlated with IDH1/2 mutation, MGMT exon 1 methylation, low Ki-67 immunostaining, increased telomeric DNA content, absence of functional ATRX protein and level of HTERT gene expression. In multivariate analysis, we observed a trend to a correlation between elevated TERRA levels and increased survival. Interestingly, the C-circles assay allowed to detect ALT activation in glioblastomas exhibiting wild-type IDH1/2 and ATRX expression. These results suggest that, after the correlations uncovered here have been confirmed on larger numbers of tumors, telomeric markers might be useful in improving diagnosis. They also point out to the utility of using the specific, sensitive and quantitative C-circle and Telo/Alu assays that can work with as few as 30 ng of tumor DNA.

Citing Articles

Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: update.

Mandelberg N, Hodges T, Wang T, McGranahan T, Olson J, Orringer D J Neurooncol. 2025; 172(1):195-218.

PMID: 39747718 DOI: 10.1007/s11060-024-04898-7.


Unveiling the mysteries of extrachromosomal circular DNA: from generation to clinical relevance in human cancers and health.

Wang Z, Yu J, Zhu W, Hong X, Xu Z, Mao S Mol Cancer. 2024; 23(1):276.

PMID: 39707444 PMC: 11660679. DOI: 10.1186/s12943-024-02187-5.


Identification of alternative lengthening of telomeres-related genes prognosis model in hepatocellular carcinoma.

Zeng F, Chen Y, Lin J BMC Cancer. 2024; 24(1):1386.

PMID: 39529015 PMC: 11555837. DOI: 10.1186/s12885-024-13146-0.


The Role of Glia Telomere Dysfunction in the Pathogenesis of Central Nervous System Diseases.

Papageorgakopoulou M, Bania A, Lagogianni I, Birmpas K, Assimakopoulou M Mol Neurobiol. 2024; 61(8):5868-5881.

PMID: 38240992 PMC: 11249767. DOI: 10.1007/s12035-024-03947-6.


Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants.

Stundon J, Ijaz H, Gaonkar K, Kaufman R, Jin R, Karras A Neuro Oncol. 2022; 25(7):1331-1342.

PMID: 36541551 PMC: 10326481. DOI: 10.1093/neuonc/noac278.


References
1.
Louis D, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee W . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6):803-20. DOI: 10.1007/s00401-016-1545-1. View

2.
Bower K, Napier C, Cole S, Dagg R, Lau L, Duncan E . Loss of wild-type ATRX expression in somatic cell hybrids segregates with activation of Alternative Lengthening of Telomeres. PLoS One. 2012; 7(11):e50062. PMC: 3502299. DOI: 10.1371/journal.pone.0050062. View

3.
Broccoli D, Godley L, Donehower L, Varmus H, de Lange T . Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol Cell Biol. 1996; 16(7):3765-72. PMC: 231372. DOI: 10.1128/MCB.16.7.3765. View

4.
McDonald K, McDonnell J, Muntoni A, Henson J, Hegi M, von Deimling A . Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival. J Neuropathol Exp Neurol. 2010; 69(7):729-36. DOI: 10.1097/NEN.0b013e3181e576cf. View

5.
Pickett H, Reddel R . Molecular mechanisms of activity and derepression of alternative lengthening of telomeres. Nat Struct Mol Biol. 2015; 22(11):875-80. DOI: 10.1038/nsmb.3106. View